BR0208221A - Combinação de uma taxano e uma cinase dependente de ciclina - Google Patents

Combinação de uma taxano e uma cinase dependente de ciclina

Info

Publication number
BR0208221A
BR0208221A BR0208221-7A BR0208221A BR0208221A BR 0208221 A BR0208221 A BR 0208221A BR 0208221 A BR0208221 A BR 0208221A BR 0208221 A BR0208221 A BR 0208221A
Authority
BR
Brazil
Prior art keywords
dependent kinase
taxane
combination
cyclin dependent
given
Prior art date
Application number
BR0208221-7A
Other languages
English (en)
Inventor
Marie-Christine Bissery
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BR0208221A publication Critical patent/BR0208221A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMBINAçãO DE UM TAXANO E UMA CINASE DEPENDENTE DE CICLINA". A invenção refere-se a uma composição farmacêutica compreendida por Taxol^ <32>^, Taxotere^ <32>^, ou derivados e uma cinase dependente de ciclina é descrita, assim como uma forma de administração onde o taxano é dado intermitentemente e a cinase dependente de ciclina é dada repetidamente dentro do mesmo ciclo.
BR0208221-7A 2001-03-23 2002-03-22 Combinação de uma taxano e uma cinase dependente de ciclina BR0208221A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27794801P 2001-03-23 2001-03-23
US30269201P 2001-07-05 2001-07-05
US33491601P 2001-12-04 2001-12-04
PCT/EP2002/004083 WO2002076484A2 (en) 2001-03-23 2002-03-22 Combination of a taxane and a cyclin-dependent kinase inhibitor

Publications (1)

Publication Number Publication Date
BR0208221A true BR0208221A (pt) 2004-03-02

Family

ID=27402954

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0208221-7A BR0208221A (pt) 2001-03-23 2002-03-22 Combinação de uma taxano e uma cinase dependente de ciclina

Country Status (33)

Country Link
US (2) US20020182204A1 (pt)
EP (1) EP1372652B1 (pt)
JP (1) JP2004521140A (pt)
KR (1) KR100879712B1 (pt)
CN (1) CN1498107A (pt)
AR (1) AR034222A1 (pt)
AT (1) ATE395917T1 (pt)
AU (1) AU2002312815B2 (pt)
BR (1) BR0208221A (pt)
CA (1) CA2441441C (pt)
CY (1) CY1110449T1 (pt)
CZ (1) CZ301423B6 (pt)
DE (1) DE60226710D1 (pt)
DK (1) DK1372652T3 (pt)
EA (1) EA007815B1 (pt)
ES (1) ES2305253T3 (pt)
HR (1) HRPK20030766B3 (pt)
HU (1) HU229258B1 (pt)
IL (2) IL158058A0 (pt)
ME (1) MEP16408A (pt)
MX (1) MXPA03007743A (pt)
NO (1) NO332441B1 (pt)
NZ (1) NZ527655A (pt)
PE (1) PE20020907A1 (pt)
PL (1) PL206118B1 (pt)
PT (1) PT1372652E (pt)
RS (1) RS50681B (pt)
SI (1) SI1372652T1 (pt)
SK (1) SK287481B6 (pt)
TW (1) TWI355935B (pt)
UY (1) UY27220A1 (pt)
WO (1) WO2002076484A2 (pt)
ZA (1) ZA200307381B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE361746T1 (de) * 2002-03-06 2007-06-15 Medical Res And Education Trus Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin
AU2003287081A1 (en) * 2002-10-16 2004-05-04 Ilex Products, Inc. Clofarabine and taxane chemotherapy combination
EP1558242B1 (en) * 2002-11-06 2008-12-24 Cyclacel Limited Combination comprising docetaxel and a cdk inhibitor
ES2390237T3 (es) * 2006-02-10 2012-11-07 Nerviano Medical Sciences S.R.L. Combinaciones que comprenden un inhibidor de cdk y un anticuerpo anti-factor de crecimiento o un agente antimitótico
BR112013012313A2 (pt) * 2010-11-19 2019-09-24 Piramal Entpr Ltd combinação farmacêutica de paclitaxel e um inibidor de cdk
BR112013025410A2 (pt) * 2011-04-01 2016-12-20 Astrazeneca Ab tratamento terapêutico
WO2013079964A1 (en) 2011-11-30 2013-06-06 Astrazeneca Ab Combination treatment of cancer
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
AU2195297A (en) * 1996-02-20 1997-09-02 Sloan-Kettering Institute For Cancer Research Combinations of pkc inhibitors and therapeutic agents for treating cancers

Also Published As

Publication number Publication date
AR034222A1 (es) 2004-02-04
CA2441441A1 (en) 2002-10-03
IL158058A0 (en) 2004-03-28
PT1372652E (pt) 2008-07-24
NO332441B1 (no) 2012-09-17
EA007815B1 (ru) 2007-02-27
HUP0303589A2 (hu) 2004-03-01
ES2305253T3 (es) 2008-11-01
IL158058A (en) 2010-02-17
PL367702A1 (en) 2005-03-07
SK11692003A3 (sk) 2004-03-02
NO20034124L (no) 2003-09-16
CZ20032551A3 (en) 2004-07-14
US20020182204A1 (en) 2002-12-05
UY27220A1 (es) 2002-09-30
ZA200307381B (en) 2005-03-30
WO2002076484A3 (en) 2003-01-03
TWI355935B (en) 2012-01-11
RS50681B (sr) 2010-06-30
EP1372652B1 (en) 2008-05-21
MXPA03007743A (es) 2004-11-12
HU229258B1 (en) 2013-10-28
CZ301423B6 (cs) 2010-02-24
AU2002312815B2 (en) 2006-08-24
US20060128640A1 (en) 2006-06-15
HRP20030766A2 (en) 2005-06-30
HUP0303589A3 (en) 2007-05-02
JP2004521140A (ja) 2004-07-15
EP1372652A2 (en) 2004-01-02
CY1110449T1 (el) 2015-04-29
KR100879712B1 (ko) 2009-01-22
ATE395917T1 (de) 2008-06-15
SK287481B6 (sk) 2010-11-08
DK1372652T3 (da) 2008-09-22
WO2002076484A2 (en) 2002-10-03
PL206118B1 (pl) 2010-07-30
DE60226710D1 (de) 2008-07-03
HRPK20030766B3 (en) 2006-11-30
MEP16408A (en) 2010-10-10
KR20030086318A (ko) 2003-11-07
PE20020907A1 (es) 2002-12-19
CN1498107A (zh) 2004-05-19
NZ527655A (en) 2006-03-31
CA2441441C (en) 2009-05-26
EA200301053A1 (ru) 2004-02-26
NO20034124D0 (no) 2003-09-16
SI1372652T1 (sl) 2008-10-31
YU69503A (sh) 2006-08-17

Similar Documents

Publication Publication Date Title
SE0301700D0 (sv) Novel compounds
CY1106468T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
EA200700168A1 (ru) Производные замещенной циклической мочевины, их получение и их фармацевтическое применение в качестве ингибиторов киназы
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
SE0302811D0 (sv) Novel compounds
CY1109568T1 (el) Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
ATE433447T1 (de) Pyrimiidinverbindungen
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
TW200621745A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
SE0301653D0 (sv) Novel compounds
MA32776B1 (fr) Inhibiteurs de l&#39;akt et de la p70 s6 kinase
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
ATE357228T1 (de) Feste pharmazeutische formulierung enthaltend modafinil
CY1110449T1 (el) Συνδυασμος δοκεταξελης και φλαβοπιριδinολης
SE0303541D0 (sv) New compounds
MXPA03010158A (es) Sulfonamidas.
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
DE69815100D1 (de) Zusammensetzungen, die dolastatin-15-analoge in kombination mit taxane und dessen derivaten enthalten
SE0300457D0 (sv) Novel compounds
WO2004056832A3 (en) Epothilone derivatives
EA200701881A1 (ru) 1,3-тиазол-5-карбоксамиды, используемые в качестве противораковых химиотерапевтических агентов

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.